Blog

Day 3 at iGEM Competition: Our Project Presentation – Babak Lab

Photo from The Babak Lab/LinkedIn

Oct 27, 2024, 08:26

Day 3 at iGEM Competition: Our Project Presentation – Babak Lab

“Day 3 at iGEM Competition: Our Project Presentation!

Today was a big day for CityU iGEM team as we presented our project to the iGEM Community! We’re tackling the pressing issue of counterfeit cancer drugs with a solution focused on Bevacizumab, a life-saving cancer treatment.

Our approach uses a rapid, affordable, and sensitive aptamer-based test that makes it easy to detect counterfeit drugs—even in regions with limited resources.

Sharing our work and receiving valuable feedback from other teams and experts was incredibly rewarding. We’re excited to keep pushing forward and make a real difference in healthcare access and quality!

Stay tuned as we keep the momentum going!

Watch our video for more details.”

Maria Babak, Head of The Babak Lab and an Assistant Professor at the City University of Hong Kong, shared this post on LinkedIn, adding:

“Fantastic work, CityU iGEM team! Presenting a solution to a critical global issue is no small feat. Your dedication to making healthcare safer and more accessible is truly inspiring—keep up the amazing momentum!”

More posts featuring Babak Lab and Maria Babak on oncodaily.com

Dr. Maria (Masha) Babak is the Head of The Babak Lab and an Assistant Professor at the City University of Hong Kong. In November 2020, she joined the City University of Hong Kong as an assistant professor. Dr. Babak received the Graeme Hanson-AsBIC Early Career Award in 2022.

Her research interests are at the intersection of chemistry, biology, and medicine, with a focus on the discovery and preclinical development of anticancer drugs for resistant and aggressive cancers with limited treatment options, such as malignant pleural mesothelioma and brain metastases. She received the Yvonne Award by OncoDaily in the “mentorship” category.